Zobrazeno 1 - 10
of 229
pro vyhledávání: '"H.-G. Klingemann"'
Publikováno v:
Scandinavian Journal of Haematology. 27:253-262
Bleeding is a common complication in patients suffering from multiple myeloma. In some cases a defect in fibrin formation has been suggested as one possible cause of haemorrhagic tendency. As shown in this investigation the defect in fibrin formation
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 106:775-778
Selective serum IgA deficiency and follicular lymphatic hyperplasia of the terminal ileum were observed in a 30-year-old patient. Due to the relative ileal stenosis he complained of colicky abdominal pains particularly after flatulant food. There was
Autor:
H.-G. Klingemann, K. Havemann
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 109:1816-1821
Publikováno v:
The Journal of Immunology. 146:1484-1489
Members of the beta 1 subfamily of heterodimeric integrins, such as the fibronectin receptors alpha 5 beta 1 and alpha 4 beta 1, are expressed on human T lymphocytes. The presence of these two adhesion receptors on T lymphocytes suggests an involveme
Autor:
H-G, Klingemann
Publikováno v:
Cytotherapy. 7(1)
Not until recently have Natural killer (NK) cells stepped out of the shadow of T-cells to be considered for cellular therapy of malignant diseases. This evolution has been facilitated by the discovery of specific receptors on NK cells that interact w
Publikováno v:
Cytotherapy. 6(5)
Background DC are a promising immunotherapeutic for treatment of infectious/malignant disease. For clinical trials, immature DC generated from precursor cells such as monocytes, using serum-free media containing GM-CSF and IL-4, can be matured with s
Autor:
H G, Klingemann, H J, Deeg
Publikováno v:
Cancer treatment and research. 108
Autor:
C L, Toze, J D, Shepherd, J M, Connors, N J, Voss, R D, Gascoyne, D E, Hogge, H G, Klingemann, S H, Nantel, T J, Nevill, G L, Phillips, D E, Reece, H J, Sutherland, E A, Conneally, M J, Barnett
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 11
Allogeneic bone marrow transplantation (BMT) has been used in patients with low-grade lymphoma (LGL) and chronic lymphocytic leukemia (CLL) with the goal of achieving long-term disease-free survival.Twenty-nine patients with these diagnoses (LGL = 19
Autor:
H.-G. Klingemann
Publikováno v:
A Guide to Blood and Marrow Transplantation ISBN: 9783642621222
Stem cell transplantation, once a salvage procedure for patients with resistant and end-stage hematological malignancies, is now generally performed earlier in the patient’s disease course. Patients in remission are usually in good physical conditi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ac6cdbea22f3fe02c079cc1781a8fd4
https://doi.org/10.1007/978-3-642-18248-8_3
https://doi.org/10.1007/978-3-642-18248-8_3
Autor:
H.-G. Klingemann
Publikováno v:
A Guide to Blood and Marrow Transplantation ISBN: 9783642621222
A comparison of disease-free survivals after various types of hemotopoietic transplants, suggest that alloreactive T-cells are important in preventing relapse after transplant. For example, the recurrence rate for AML is about 60% after a transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6721a33a07d630b9339e3025d9c317d
https://doi.org/10.1007/978-3-642-18248-8_11
https://doi.org/10.1007/978-3-642-18248-8_11